US government gives Moderna $176 million to develop an mRNA vaccine for bird flu, aiming to be better prepared for health emergencies following lessons from Covid-19.
Bird flu, though currently not a major threat to humans, could mutate, prompting the need for a quick-response vaccine.
The funding supports Moderna’s efforts to advance and test a vaccine against H5N1 avian influenza, potentially enhancing readiness against future outbreaks.
Source: BBC
https://www.bbc.com/news/articles/c51ywpxp43lo